Neural Regeneration Research, 2025 · DOI: https://doi.org/10.4103/NRR.NRR-D-24-00035 · Published: November 1, 2025
This research investigates the difference in pain response between male and female rats after spinal cord injury (SCI). Specifically, it explores how a drug called tamoxifen (TAM) affects pain, and if there are differences in the expression of certain proteins (glutamate transporters) in the spinal cord between males and females. The study found that tamoxifen reduced pain only in female rats, suggesting a sex-specific effect. They also discovered that males and females have different levels of certain glutamate transporters in their spinal cords. These findings could lead to new ways of treating chronic pain after SCI, potentially through personalized medicine that considers sex differences.
The sexually dimorphic expression of glutamate transporters suggests the potential for personalized pain management strategies following SCI, tailored to the patient's sex.
Identifying the role of EAATs in modulating chronic pain after SCI could lead to the development of non-opioid drugs for pain management.
Future studies should investigate optimal tamoxifen dosage for pain relief in males, given the higher levels of ER-α in female spinal cords.